Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Brookfield Oaktree Holdings, LLC

Ticker
OAK-PA
Sector
Industry
Report date
August 12, 2026
Valye AI Score

94

Very high visibility
Recent developments
Recent developments summary

Recent news items are not directly related to Brookfield Oaktree Holdings, LLC but provide market context on convertible notes offerings, contracts, and earnings calls in related sectors.

Recent developments:
  • Realty Income priced an upsized $875 million convertible notes offering and plans a share buyback [N1].
  • Skanska signed an additional contract for a medical office building valued at $68 million [N2].
  • Bicara Therapeutics reported an expanded Q2 net loss with Phase 3 study enrollment on track [N3].
  • Laekna's LAE002 NDA was accepted in China for HR+/HER2- breast cancer [N4].
  • Realty Income plans a $750 million convertible notes offering and share repurchase [N5].
  • Xperi held its Q2 2026 earnings call [N6].
  • Par Pacific held its Q2 2026 earnings call [N7].
  • Hudson Technologies held its Q2 2026 earnings call [N8].
Overview

Brookfield Oaktree Holdings, LLC is a limited liability holding company that holds limited partner interests in private investment funds managed by Oaktree Capital Management. The company’s primary business involves capital commitments to Oaktree Opportunities Fund XI and Fund XII, with funding provided by its sole Class A unitholder. Distributions from these investments are intended to benefit the Class A unitholder, and preferred unitholders rely on distributions from Oaktree Capital I for payments. The company operates under a complex legal and tax structure, including provisions that limit remedies for preferred unitholders and modify fiduciary duties of officers and directors. The company is not considered an investment company under the Investment Company Act, which influences its regulatory environment and operational flexibility.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Brookfield Oaktree Holdings, LLC operates as a holding company with capital commitments to Oaktree Opportunities Funds XI and XII, funded by its sole Class A unitholder. The company’s distributions to preferred unitholders depend on distributions from Oaktree Capital I and are subject to regulatory, contractual, and tax complexities. As of June 30, 2026, the company reported net income of $55.9 million and EPS of $0.41, with cash and equivalents of $831.7 million as of December 31, 2018.

Scenarios for OAK-PA

Bull case model:

Brookfield Oaktree Holdings benefits from its strategic capital commitments to Oaktree-managed private funds, which provide access to diversified investment opportunities. The company’s structure allows it to leverage Oaktree’s asset management capabilities and potentially generate income through distributions. Its substantial cash holdings and reported net income as of mid-2026 indicate operational stability. The company’s legal and tax structuring aims to optimize returns for preferred unitholders within regulatory frameworks.

Bear case model:

The company’s preferred unitholders face risks due to limited remedies and modified fiduciary duties of officers and directors, which may reduce protections against adverse actions. Distributions to preferred unitholders depend on Oaktree Capital I’s ability to generate sufficient cash flows, which is not guaranteed. Complex U.S. tax considerations, including potential unrelated business taxable income and effectively connected income, may create tax liabilities for certain holders. Regulatory risks related to the Investment Company Act and holding company structure may impose operational constraints. The company’s liquidity ratios are partially undisclosed, limiting full financial transparency.

Moat:

The company’s moat derives from its affiliation with Oaktree Capital Management, a well-established asset management firm with access to private investment funds. Its capital commitments to these funds and the structure of its preferred units create a specialized investment vehicle that benefits from Oaktree’s asset management expertise and fund performance. However, the company’s reliance on distributions from Oaktree Capital I and the limited remedies available to preferred unitholders may constrain its financial flexibility and investor protections.

Risks overview
Risks summary
The most significant risks relate to regulatory classification under the Investment Company Act, dependency on distributions from Oaktree Capital I for preferred unit payments, and limited investor protections due to governance provisions.
Risks details:

• Regulatory Risk: If the company or its private funds were deemed an investment company under the Investment Company Act, regulatory restrictions could materially adversely affect its business operations and financial condition.
• Distribution Risk: Distributions to preferred unitholders depend on distributions from Oaktree Capital I, which may be insufficient to meet preferred unit payments.
• Governance and Fiduciary Duty Limitations: The operating agreement limits remedies available to preferred unitholders and modifies fiduciary duties of officers and directors, potentially reducing investor protections.
• Tax Complexity: Preferred units involve complex U.S. federal income tax issues, including unrelated business taxable income for tax-exempt holders and effectively connected income for non-U.S. holders, which may result in adverse tax consequences.
• Liquidity and Financial Transparency: Liquidity ratios are incomplete due to missing current assets and liabilities data, limiting full assessment of short-term financial health.

FINAL FORECAST FOR OAK-PA

Final take one line
Brookfield Oaktree Holdings, LLC has a well-documented asset management investment structure with clear regulatory and tax complexities and limited preferred unitholder protections.
Final take 12 to 24 month view

Business trends: The company continues capital commitments to Oaktree-managed funds and relies on distributions from Oaktree Capital I to service preferred units.
Execution milestones: Monitoring regulatory compliance under the Investment Company Act and managing distributions to preferred unitholders remain key operational focuses.
Key risks: Regulatory classification risks, dependency on distributions from affiliated entities, governance limitations, and complex tax implications for investors.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

94
LLM visibility overview
LLM Visibility known facts
  • Brookfield Oaktree Holdings, LLC is a limited liability holding company with no independent means of generating revenues and holds limited partner interests in Oaktree Opportunities Fund XI, L.P. and Oaktree Opportunities Fund XII, L.P., with capital commitments of $750 million each, plus an additional $46.2 million commitment to Fund XII as of December 31, 2025.
  • The company’s sole Class A unitholder or its affiliates contribute cash to fund these investments, and distributions from these investments are intended for the benefit of the Class A unitholder, not the preferred unitholders.
  • As of December 31, 2025, the company had funded $637.5 million of the $750 million commitment to Fund XI and $218.9 million of the $796.2 million commitment to Fund XII.
  • $379.0 million of the investment interest was pledged as collateral for two non-recourse credit facilities of an affiliate, limiting potential exposure to the pledged interests.
  • Distributions to holders of Series A and Series B preferred units have been and are generally serviced by distributions received from Oaktree Capital I, but there is no assurance these distributions will be sufficient to pay preferred unit distributions.
  • The company believes it is primarily engaged in asset management services and not an investment company under the Investment Company Act, which affects regulatory and operational constraints.
  • The operating agreement limits remedies available to preferred unitholders and modifies fiduciary duties of officers and directors, which may be detrimental to unitholders.
  • The company’s ability to make distributions to preferred unit holders may be limited by its holding company structure, Delaware law, contractual restrictions, and terms of senior securities.
  • The company’s preferred units are subject to complex U.S. federal income tax considerations, including potential unrelated business taxable income (UBTI) for tax-exempt holders and effectively connected income (ECI) for non-U.S. holders.
  • Holders of preferred units may face state and local tax obligations and filing requirements.
  • Financial snapshot as of June 30, 2026, includes net income of $55,867,000 and basic and diluted EPS of $0.41 per share, with cash and equivalents of $831,727,000 as of December 31, 2018.
  • Liquidity ratios are not fully disclosed due to missing current assets and liabilities data.
  • No material changes to risk factors were reported in the latest 10-Q filing dated August 11, 2026.
Sources
Sources - Context summary

Generated 2026-08-12

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-24 | 10-K
  • S2 | 2026-08-11 | 10-Q
Sources - News headlines
  • N1 | 2026-08-12 | www.nasdaq.com | Realty Income Prices Upsized $875 Mln Convertible Notes Offering; Plans Share Buyback | https://www.nasdaq.com/articles/realty-income-prices-upsized-875-mln-convertible-notes-offering-plans-share-buyback
  • N2 | 2026-08-12 | www.nasdaq.com | Skanska Inks Additional Contract For Medical Office Building For $68 Mln | https://www.nasdaq.com/articles/skanska-inks-additional-contract-medical-office-building-68-mln
  • N3 | 2026-08-12 | www.nasdaq.com | Bicara Therapeutics Q2 Net Loss Expands; Phase 3 FORTIFI-HN01 Study Enrollment On Track | https://www.nasdaq.com/articles/bicara-therapeutics-q2-net-loss-expands-phase-3-fortifi-hn01-study-enrollment-track
  • N4 | 2026-08-12 | www.nasdaq.com | Laekna's LAE002 NDA Accepted In China For HR+/HER2- Breast Cancer | https://www.nasdaq.com/articles/laeknas-lae002-nda-accepted-china-hr-her2-breast-cancer
  • N5 | 2026-08-12 | www.nasdaq.com | Realty Income Plans $750 Mln Convertible Notes Offering, Share Repurchase | https://www.nasdaq.com/articles/realty-income-plans-750-mln-convertible-notes-offering-share-repurchase
  • N6 | 2026-08-12 | www.nasdaq.com | Xperi (XPER) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/xperi-xper-q2-2026-earnings-call-transcript
  • N7 | 2026-08-12 | www.nasdaq.com | Par Pacific (PARR) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/par-pacific-parr-q2-2026-earnings-call-transcript
  • N8 | 2026-08-12 | www.nasdaq.com | Hudson Technologies (HDSN) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/hudson-technologies-hdsn-q2-2026-earnings-call-transcript
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine